Mayer Davidson to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Mayer Davidson has written about Dose-Response Relationship, Drug.
Connection Strength
0.373
-
Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care. 2014; 37(1):3-4.
Score: 0.106
-
U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
Score: 0.080
-
Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
Score: 0.056
-
Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population. Diabetes Care. 2004 Jul; 27(7):1741-2.
Score: 0.055
-
Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993 Oct; 58(4):555-60.
Score: 0.026
-
Successful treatment of markedly symptomatic patients with type II diabetes mellitus using high doses of sulfonylurea agents. West J Med. 1992 Aug; 157(2):199-200.
Score: 0.024
-
Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status. West J Med. 1985 Feb; 142(2):219-29.
Score: 0.014
-
Insulin binding and action in isolated rat hepatocytes: effect of obesity and fasting. Am J Physiol. 1982 Sep; 243(3):E240-5.
Score: 0.012